Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 801 to 825 of about 5880

Previous 25

Website Changes

11/02/2020

The Man Behind The Musella Foundation

10/29/2020

Musella Foundation Accomplishments

10/29/2020

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

10/26/2020

Evolution of radiotherapies for brain tumors - the story of GammaTile Therapy.

10/19/2020

Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study

10/15/2020

Musella Foundation Copayment Assistance Program Closed to New patients

10/08/2020

What would YOU do if you were diagnosed with GBM?

10/04/2020

Brain TUmor Webinar Tonight!

10/04/2020

Musella Foundation Copay Assistance Program Status

09/29/2020

Musella Foundation Copay Assistance Program is now open!

09/28/2020

xCures announces the launch of a Compassionate Use program for ulixertinib (BVD-523)

09/18/2020

Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer

09/17/2020

Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control

09/14/2020

2nd Annual Brain Tumor TOGETHER and ACTION Day

09/11/2020

Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

09/09/2020

New Webinar Added: Assessment of Treatment Response to Established and Novel Therapies in Glioblastoma Patients using Metabolic and Physiologic MR Imaging Techniques

09/02/2020

Return to work following diagnosis of low-grade glioma

08/31/2020

Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy

08/29/2020

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

08/25/2020

GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases

08/24/2020

Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme

08/24/2020

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas

08/24/2020

The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma

08/24/2020

A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma

08/23/2020

Ketone-Supressing Drug Combats Rare Brain Cancer in Mice

Our privacy / cookie policy has changed.
Click HERE to read it!